Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Vasculitis Post Immune Checkpoint Inhibitors Therapy
Sehrish Qureshi
, Naszrin Arani
,
Maria Suarez-Almazor
, Amanda Tchakarov
,
Mehmet Altan
,
Ala Abudayyeh
Health Services Research
Thoracic Head & Neck Medical Oncology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vasculitis Post Immune Checkpoint Inhibitors Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Proteinase 3
100%
Vasculitis
100%
Antineutrophil Cytoplasmic Antibody
100%
Immune Checkpoint Therapy
100%
Anti-PR3
100%
Tumor Response
50%
Rituximab
50%
Creatinine
50%
Renal Tumor
50%
Plasmapheresis
50%
Multiorgan Involvement
50%
Renal Remission
50%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculitis
100%
Myeloblastin
100%
Immune Checkpoint Inhibitor
100%
Neutrophil Cytoplasmic Antibody
100%
Diseases
50%
Neoplasm
50%
Creatinine
50%
Remission
50%
Rituximab
50%
Steroid
50%
Medicine and Dentistry
Vasculitis
100%
Myeloblastin
100%
Neutrophil Cytoplasmic Antibody
100%
Immune Checkpoint Inhibitor
100%
Diseases
50%
Neoplasm
50%
Rituximab
50%
Creatinine
50%
Plasmapheresis
50%
Steroid
50%